These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38639945)

  • 1. Bacterial Subspecies Linked With Aggressive Colorectal Cancer Tumors.
    Harris E
    JAMA; 2024 May; 331(18):1526. PubMed ID: 38639945
    [No Abstract]   [Full Text] [Related]  

  • 2. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
    Castellarin M; Warren RL; Freeman JD; Dreolini L; Krzywinski M; Strauss J; Barnes R; Watson P; Allen-Vercoe E; Moore RA; Holt RA
    Genome Res; 2012 Feb; 22(2):299-306. PubMed ID: 22009989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients.
    Fukugaiti MH; Ignacio A; Fernandes MR; Ribeiro Júnior U; Nakano V; Avila-Campos MJ
    Braz J Microbiol; 2015; 46(4):1135-40. PubMed ID: 26691472
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
    Repass J; Maherali N; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26882501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
    Lin R; Han C; Ding Z; Shi H; He R; Liu J; Qian W; Zhang Q; Fu X; Deng X; Zhou S; Hou X
    Cancer Lett; 2020 Dec; 495():165-179. PubMed ID: 32920199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
    Slade DJ
    Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
    Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
    Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial Fusobacterium nucleatum clade in colorectal cancer.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2024 Jun; 21(6):375. PubMed ID: 38627536
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic Transformation of Fusobacterium nucleatum.
    Yoshida A; Ikegami A
    Methods Mol Biol; 2021; 2210():43-50. PubMed ID: 32815126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.